Capitolis Liquid Global Markets’s Apellis Pharmaceuticals APLS Stock Holding History

Capitolis Liquid Global Markets’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,013,500	Closed	-$40.8M	–	323
2026 Q1	$40.8M	Buy	+1,013,500	New	+$21.8M	0.26%	79
2025 Q3	–	Sell	-544,600	Closed	-$9.43M	–	244
2025 Q2	$9.43M	Buy	+544,600	New	+$10.1M	0.07%	142

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capitolis Liquid Global Markets's APLS Position: Q2 2026 in Review

Capitolis Liquid Global Markets sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,013,500 shares — an estimated $40.8M sold.

Capitolis Liquid Global Markets first reported a position in APLS in Q2 2025 and held it in 2 quarters. The position peaked at $40.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Capitolis Liquid Global Markets reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Capitolis Liquid Global Markets sold 1,013,500 Apellis Pharmaceuticals shares in Q2 2026, an estimated $40.8M.
Capitolis Liquid Global Markets first reported a position in Apellis Pharmaceuticals in Q2 2025 and held it in 2 quarters.
Capitolis Liquid Global Markets's Apellis Pharmaceuticals position peaked at $40.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.